CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 223 enrolled
Drug / intervention
FeZnPM +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02233764
NCT02233764N/ACompleted

Effect of Iron- and Zinc-Biofortified Pearl Millet (ICTP8203-Fe) Consumption on Growth and Immunity in Children Aged 12-18 Months in India

Cornell University·interventional·Posted Sep 8, 2014·Updated Mar 9, 2026

In Brief

A clinical study evaluating FeZnPM and CtrlPM for Iron Deficiency and Zinc Deficiency. Completed, enrolled 223 participants across 3 sites.

Detailed Summary

In this study, iron- and zinc-biofortified pearl millet will be fed to young children in Mumbai, Maharashtra, India over a period of nine months to measure iron status, growth and immune function in comparison to children receiving non-biofortified pearl millet.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndia

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 8, 2014
Enrollment StartMay 8, 2017
Primary CompletionJul 16, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.8 years ago

Interventions

FeZnPMother

Iron and zinc biofortified pearl millet will be consumed three times per day, six days per week, for 9 months. Children are anticipated to consume 25-30 grams of the pearl millet at each feeding. The pearl millet will be prepared using a variety of recipes such as porridges, breads, and biscuits.

CtrlPMother

Conventional pearl millet will be consumed three times per day, six days per week, for 9 months. Children are anticipated to consume 25-30 grams of the pearl millet at each feeding. The pearl millet will be prepared using a variety of recipes such as porridges, breads, and biscuits.